alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 99.1

 

**ANNUAL SERVICER’S CERTIFICATE**

 

**TARGET NATIONAL BANK (FORMERLY RETAILERS NATIONAL BANK)**

 

**TARGET CREDIT CARD MASTER TRUST**

 

 

The undersigned, a dulyauthorized representative of Target National Bank, (formerly known asRetailers National Bank) as Servicer (“TNB”), pursuant to the Amended andRestated Pooling and Servicing Agreement dated as of April 28, 2000, assupplemented by the Series 2001-1 Supplement and the Series 2002-1 Supplement(as may be amended and supplemented from time to time, the “Agreement”), amongTarget Receivables Corporation, as Transferor, TNB, as Servicer, and WellsFargo Bank, National Association, (successor by merger to Wells Fargo BankMinnesota, National Association) as Trustee, does hereby certify that:

 

1.                                       TNB is, as of the date hereof, the Servicerunder the Agreement.  Capitalized termsused in this Certificate have their respective meanings as set forth in theAgreement.

 

2.                                       The undersigned is a Servicing Officer who isduly authorized pursuant to the Agreement to execute and deliver thiscertificate to the Trustee.

 

3.                                       A review of the activities of the Servicerduring the fiscal year ended January 1, 2005, and of its performance under theAgreement was conducted under my supervision.

 

4.                                       Based on such review, the Servicer has, tothe best of my knowledge, performed in all material respects its obligationsunder the Agreement throughout such year and no default in the performance ofsuch obligations has occurred or is continuing except as set forth in paragraph5 below.

 

5.                                       The following is a description of eachdefault in the performance of the Servicer’s obligations under the provisionsof the Agreement known to me to have been made by the Servicer during thefiscal year ended January 1, 2005 which sets forth in detail (i) the nature ofeach default, (ii) the action taken by the Servicer, if any, to remedy each suchdefault and (iii) the current status of each such default: None.

 

 

IN WITNESS WHEREOF, theundersigned has duly executed this Certificate as of the 28th day of March,2005.

 
|    | **TARGET  NATIONAL BANK,**          |
|---------|-------------------------------------|
|    | **as  Servicer,**                   |
|    |                                |
|    |                                |
| **By:** | /s/ Thomas A. Swanson               |   |
|    | Name: Thomas A. Swanson             |
|    | Title: Vice President & Cashier |
§ 582.1685 Rennet. ( a ) *Product.* Rennet (rennin).
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Exhibit 10.18


 


Eastern Virginia Bankshares, Inc.


Base Salaries for Executive Officers


 


As of March 1, 2017


 


The current base salaries for the executive
officers of Eastern Virginia Bankshares, Inc. (the “Company”) are as follows:


 


	Joe A. Shearin
 President and Chief Executive Officer of the Company and EVB	 	 	$‎‎424,200	 
	 	 	 	 	 
	J. Adam Sothen
 Chief Financial Officer of the Company and Executive Vice President and Chief Financial Officer of EVB
 
	 	 	$‎193,785	 
	 	 	 	 	 
	James S. Thomas
 Executive Vice President and Chief Credit Officer of EVB
 
	 	 	$‎177,353	 
	 	 	 	 	 
	Douglas R. Taylor
 Executive Vice President and Chief Risk Officer of EVB
 
	 	 	$‎156,827	 
	 	 	 	 	 
	Ann-Cabell Williams
 Executive Vice President and Chief Channel Distribution Officer of EVB
 
	 	 	$‎156,827	 
	 	 	 	 	 
	Bruce T. Brockwell
 Executive Vice President and Chief Banking Officer of EVB
 
	 	 	$‎167,592	 
	 	 	 	 	 
	Mark C. Hanna
 Executive Vice President and Regional Executive of EVB	 	 	$‎234,090	 
	 	 	 	 	 
	Dianna B. Emery
 Executive Vice President and Chief Operations Officer of EVB	 	 	$‎156,097
##### 



Exhibit 31.2 CERTIFICATION REQUIRED BY
RULE 13a-14(a) OR RULE 15d-14(d) AND UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, Brian R. Schaefgen, certify that:  1.
    
    I have reviewed this Annual Report on Form 10-K/A of Ambassadors
International, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this report;4.
    
    The registrants other certifying officer(s) and I are responsible
for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:  (a)
    
    Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the
period in which this report is being prepared;(b)
    
    Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such
evaluation; and(c)
    
    Disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth
fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting; and  5.
    
    The registrants other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the
registrants board of directors (or persons performing the equivalent
functions):  (a)
    
    All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrants
ability to record, process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrants
internal control over financial reporting. March 29, 2004 /s/ Brian R. Schaefgen
Exhibit 32 (a)
 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Form 10-Q fully complies with the requirements of Section 13 (a) or
(15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78(d)); and(2)
    
    The information contained in the Form 10-Q fairly presents in all
material respects, the financial condition and results of operations of the
Partnership.
 Date: 8-13-09
 /s/
    
    JOHN S. WHETZELL

John S. WhetzellChief Executive Officer
 A signed original of this written statement required by Section 906 has been provided to
Northland Cable Properties Seven Limited Partnership and will be retained by Northland Cable
Properties Seven Limited Partnership and furnished to the Securities and Exchange Commission or its
staff upon request.
<PAGE>

                                                                      EXHIBIT 32

    CERTIFICATIONS PURSUANT TO Section 906 OF THE SARBANES-OXLEY ACT OF 2002
                            (18 U.S.C. Section 1350)

      The undersigned, as the President and Chief Executive Officer, and
Executive Vice President and Chief Financial Officer of Exide Technologies, each
certify that

      (1) the accompanying Quarterly Report on Form 10-Q for the period ended
September 30, 2005, fully complies with the requirements of Section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

      (2) the information contained in the periodic report fairly presents, in
all material respects, the financial condition and results of operations of
Exide Technologies at the dates and for the periods indicated.

      The foregoing certification is made pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. $1350) and no purchaser or seller of
securities or any other person shall be entitled to rely upon the foregoing
certification for any other purpose.

      A signed original of this written statement required by Section 906 has
been provided to Exide Technologies and will be retained by Exide Technologies
and furnished to the Securities and Exchange Commission or its staff upon
request.

      The undersigned expressly disclaims any obligation to update the foregoing
certification except as required by law.

Date: November 9, 2005
                                            /S/ Gordon A. Ulsh
                           ----------------------------------------------------
                                              GORDON A. ULSH
                                  PRESIDENT AND CHIEF EXECUTIVE OFFICER

                                          /s/ J. Timothy Gargaro
                           ----------------------------------------------------
                                            J. TIMOTHY GARGARO
                           EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

                                       37
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Nomination of William McChesney Martin, Jr.

              																	United States. Congress. Senate. Committee on Banking, Housing, and Urban Affairs, 1970-					 and 	Eighty-Second Congress, 1951-1953. 						*Nomination of William McChesney Martin, Jr. : Hearing Before the Committee on Banking and Currency, United States Senate, Eighty-Second Congress, First Session, March 19, 1951*,												Washington: 								U.S. Government Printing Office, 										March 19, 1951,									https://fraser.stlouisfed.org/title/5333,			accessed on September 25, 2024.						    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
§ 582.5370 Inositol. ( a ) *Product.* Inositol.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
§ 522.1452 Nalorphine. ( a ) *Specifications.* Each milliliter of solution contains 5 milligrams of nalorphine hydrochloride.
( b ) *Sponsor.* See No. 000010 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* One milligram per 5 pounds; intravenously, intramuscularly, or subcutaneously.
( 2 ) *Indications for use.* Respiratory and circulatory depression in dogs resulting from overdosage of, or unusual sensitivity to, morphine and certain other narcotics. Not for depression due to any other cause.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[44 FR 6707, Feb. 2, 1979, as amended at 47 FR 36418, Aug. 20, 1982; 62 FR 63271, Nov. 28, 1997; 79 FR 16191, Mar. 25, 2014; 84 FR 39184, Aug. 9, 2019]
<PAGE>

                                                                      EXHIBIT 23



REPORT OF INDEPENDENT ACCOUNTANTS


To the Board of Directors and Shareholder of Crown Paper Co.:

We have audited the consolidated statements of operations, cash flows, and 
changes in equity for the year ended December 31, 1995 of Crown Paper Co. and 
subsidiaries, as described in Note 2, listed in the index on page 8 of this 
Form 10-K. These financial statements are the responsibility of the 
management of Crown Paper Co.  Our responsibility is to express an opinion on 
these financial statements based on our audits.

We conducted our audit in accordance with generally accepted auditing standards.
Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated results of operations and cash flows of
Crown Paper Co. and subsidiaries for the year ended December 31, 1995, in
conformity with generally accepted accounting principles.





                                        COOPERS & LYBRAND L.L.P.


Oakland, California
February 23, 1996


                                      15
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 96-6091
TAYLOR WARREN SMITH, Plaintiff - Appellant, versus MISS TROTTER, Counselor, Defendant - Appellee.
Appeal from the United States District Court for the Eastern District of Virginia, at Richmond. Ric hard L. Williams, Senior District Judge. (CA-95-783) Submitted: May 16, 1996 Decided: June 4, 1996 Before RUSSELL, LUTTIG, and WILLIAMS, Circuit Judges. Dismissed by unpublished per curiam opinion. Taylor Warren Smith, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Appellant appeals the district court's order dismissing his 42 U.S.C. § 1983 (1988) complaint. The district court assessed a filing fee in accordance with Evans v. Croom , 650 F.2d 521 (4th Cir. 1981), cert. denied , 454 U.S. 1153 (1982), and dismissed the case without prejudice when Appellant failed to comply with the fee order. We have reviewed the record and the district court's opinion accepting the magistrate judge's recommendation, and find no abuseof discretion. We therefore deny leave to proceed in forma pauperis and dismiss the appeal. We dispense with oral argument becausethe facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
EXHIBIT 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906

 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the Annual Report on Form 10-Q (the “Form 10-Q”) for the year ended June 30, 2007 of Crimson Exploration Inc. (the “Issuer”).  The undersigned hereby certifies that the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 

 

| Date:

  | August 14, 2007

  |   |
|---------------|-------------------------|--------|
|          | /s/ E. Joseph Grady     |   |
| Name:         | E. Joseph Grady         |   |
| Title:        | Chief Financial Officer |   |
|          |                    |   |
|          |                    |   |

 

A signed original of this written statement required by Section 906 has been provided to the Issuer and will be furnished to the Securities and Exchange Commission, or its staff, upon request.
§ 556.50 Amprolium. ( a ) [Reserved]
( b ) *Tolerances.* The tolerances for amprolium are: ( 1 ) *Cattle.* ( i ) Liver, kidney, and muscle: 0.5 ppm.
( ii ) Fat: 2.0 ppm.
( 2 ) *Chickens and turkeys.* ( i ) Liver and kidney: 1 ppm.
( ii ) Muscle: 0.5 ppm.
( iii ) Eggs: ( A ) Egg yolks: 8 ppm.
( B ) Whole eggs: 4 ppm.
( 3 ) *Pheasants.* ( i ) Liver: 1 ppm.
( ii ) Muscle: 0.5 ppm.
( c ) *Related conditions of use.* See §§ 520.100, 558.55, and 558.58 of this chapter.
<TABLE> <S> <C>

<ARTICLE> 9
<RESTATED>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                       6,361,407
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                            12,565,240
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                          0
<INVESTMENTS-CARRYING>                       5,111,550
<INVESTMENTS-MARKET>                         8,372,788
<LOANS>                                     70,807,897
<ALLOWANCE>                                  (751,960)
<TOTAL-ASSETS>                             106,795,763
<DEPOSITS>                                  95,037,779
<SHORT-TERM>                                 1,200,000
<LIABILITIES-OTHER>                            483,892
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     2,914,803
<OTHER-SE>                                   5,426,347
<TOTAL-LIABILITIES-AND-EQUITY>             106,795,763
<INTEREST-LOAN>                              1,863,325
<INTEREST-INVEST>                              311,353
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                             2,174,678
<INTEREST-DEPOSIT>                             737,434
<INTEREST-EXPENSE>                             753,665
<INTEREST-INCOME-NET>                        1,421,013
<LOAN-LOSSES>                                   30,000
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                              1,220,474
<INCOME-PRETAX>                                507,698
<INCOME-PRE-EXTRAORDINARY>                     507,698
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   324,058
<EPS-PRIMARY>                                      .24
<EPS-DILUTED>                                      .23
<YIELD-ACTUAL>                                       0
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                     0
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                    0
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                                    <C>
<PERIOD-TYPE>                                    6-MOS
<FISCAL-YEAR-END>                          APR-30-1998
<PERIOD-END>                               OCT-31-1998
<CASH>                                         300,782
<SECURITIES>                                         0
<RECEIVABLES>                                  606,739
<ALLOWANCES>                                         0
<INVENTORY>                                     37,576
<CURRENT-ASSETS>                               945,097
<PP&E>                                       6,886,744
<DEPRECIATION>                             (1,264,806)
<TOTAL-ASSETS>                               6,898,077
<CURRENT-LIABILITIES>                        1,599,959
<BONDS>                                      3,638,309
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    25,767,047
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 6,893,077
<SALES>                                              0
<TOTAL-REVENUES>                             1,140,028
<CGS>                                                0
<TOTAL-COSTS>                                  627,921
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             193,304
<INCOME-PRETAX>                            (1,358,884)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                 89,343
<CHANGES>                                            0
<NET-INCOME>                               (1,269,541)
<EPS-PRIMARY>                                    (.27)
<EPS-DILUTED>                                    (.27)
        

</TABLE>
§ 660.1 Antibody to Hepatitis B Surface Antigen. ( a ) *Proper name and definition.* The proper name of this product shall be Antibody to Hepatitis B Surface Antigen. The product is defined as a preparation of serum containing antibody to hepatitis B surface antigen.
( b ) *Source.* The source of this product shall be plasma or blood, obtained aseptically from animals immunized with hepatitis B surface antigen, which have met the applicable requirements of § 600.11 of this chapter, or from human donor whose blood is positive for hepatitis B surface antigen.
[40 FR 29711, July 15, 1975]